CS120991A2 - 1,5-benzothiazepinone derivatives - Google Patents

1,5-benzothiazepinone derivatives Download PDF

Info

Publication number
CS120991A2
CS120991A2 CS911209A CS120991A CS120991A2 CS 120991 A2 CS120991 A2 CS 120991A2 CS 911209 A CS911209 A CS 911209A CS 120991 A CS120991 A CS 120991A CS 120991 A2 CS120991 A2 CS 120991A2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
defined above
methoxyphenyl
dihydro
Prior art date
Application number
CS911209A
Other languages
Czech (cs)
English (en)
Inventor
Aldo Salimbeni
Saturnino Caliari
Elso Manghisi
Francesco Fici
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of CS120991A2 publication Critical patent/CS120991A2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CS911209A 1990-04-27 1991-04-26 1,5-benzothiazepinone derivatives CS120991A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20160A IT1240686B (it) 1990-04-27 1990-04-27 Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico

Publications (1)

Publication Number Publication Date
CS120991A2 true CS120991A2 (en) 1991-12-17

Family

ID=11164306

Family Applications (1)

Application Number Title Priority Date Filing Date
CS911209A CS120991A2 (en) 1990-04-27 1991-04-26 1,5-benzothiazepinone derivatives

Country Status (20)

Country Link
US (1) US5571807A (fi)
EP (1) EP0526495A1 (fi)
JP (1) JPH05506654A (fi)
CN (1) CN1056101A (fi)
AU (1) AU645317B2 (fi)
BG (1) BG97014A (fi)
BR (1) BR9106372A (fi)
CA (1) CA2081204A1 (fi)
CS (1) CS120991A2 (fi)
FI (1) FI924756A (fi)
HU (1) HU9203326D0 (fi)
IE (1) IE71033B1 (fi)
IL (1) IL97859A0 (fi)
IN (1) IN172160B (fi)
IT (1) IT1240686B (fi)
MA (1) MA22143A1 (fi)
PT (1) PT97508A (fi)
RO (1) RO111269B1 (fi)
WO (1) WO1991017153A1 (fi)
ZA (1) ZA913171B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118292T3 (es) * 1994-09-16 1998-09-16 Orion Corp Fermion Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos.
WO1996038429A1 (en) * 1995-06-01 1996-12-05 Acic (Canada) Inc. Method for the manufacture of benzothiazepine derivatives
US5559229A (en) * 1995-06-01 1996-09-24 Acic (Canada) Inc. Method for the manufacture of benzothiazepine
WO2006079077A2 (en) * 2005-01-20 2006-07-27 Acadia Pharmaceuticals Inc. Use of diltiazem or analogs thereof as modulators of ghrelin receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
IT1206505B (it) * 1983-07-22 1989-04-27 Schiapparelli Farma Nuovi derivati benzotiazepinonici, metodo per la loro preparazione e composizioni farmaceutiche che licontengono.
ES2038668T3 (es) * 1986-08-20 1993-08-01 Mcneilab, Inc. Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica.
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
ATE116643T1 (de) * 1989-04-28 1995-01-15 Tanabe Seiyaku Co Verfahren zur herstellung von 1,5- benzothiazepinderivaten.
JPH085869B2 (ja) * 1990-03-08 1996-01-24 田辺製薬株式会社 １，５−ベンゾチアゼピン誘導体の製法

Also Published As

Publication number Publication date
IT9020160A0 (it) 1990-04-27
IL97859A0 (en) 1992-06-21
AU7695491A (en) 1991-11-27
AU645317B2 (en) 1994-01-13
IT1240686B (it) 1993-12-17
WO1991017153A1 (en) 1991-11-14
BR9106372A (pt) 1993-04-27
IT9020160A1 (it) 1991-10-27
EP0526495A1 (en) 1993-02-10
MA22143A1 (fr) 1991-12-31
CN1056101A (zh) 1991-11-13
RO111269B1 (ro) 1996-08-30
PT97508A (pt) 1992-01-31
IN172160B (fi) 1993-04-17
JPH05506654A (ja) 1993-09-30
IE911411A1 (en) 1991-11-06
ZA913171B (en) 1992-02-26
CA2081204A1 (en) 1991-10-28
US5571807A (en) 1996-11-05
IE71033B1 (en) 1997-01-15
FI924756A0 (fi) 1992-10-20
HU9203326D0 (en) 1993-01-28
FI924756A (fi) 1992-10-20
BG97014A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
FI80018C (fi) Foerfarande foer framstaellning av optiskt aktiva karbazolderivat, nya r- och s- karbazolderivat.
KR920004936B1 (ko) 벤즈이미다졸 유도체의 제조방법.
CS201040B2 (en) Method of producing etherified hydroxy-benzo-diheterocyclic compounds
HUT71487A (en) Substituted benzothiazepine derivatives process for preparing them and pharmaceutical compositions of hypolididaemic activity containing said compounds
HU191785B (en) Process for the production of 1,5-benzothiazapine-derivatives
FI93106B (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
CS120991A2 (en) 1,5-benzothiazepinone derivatives
DD249271A5 (de) Verfahren zur herstellung von 9-chlor-1,5-benzothiazepin-derivaten
EP0117961B1 (fr) Nouveaux dérivés hétérocycliques substitués par un radical aminé, leurs procédé d'obtention et les compositions pharmaceutiques en renfermant
US4221798A (en) Hypotensive 2-heterocycloamino-imidazolines
JP2954962B2 (ja) ８位置換１，５―ベンゾチアゼピン誘導体
US5414006A (en) Arylalkoxythiocoumarins, the preparation thereof and therapeutic compositions containing these
FI92393C (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
HU200757B (en) Process for producing new naphthothiazepine derivatives and pharmaceutical compositions such compounds
JPH0559107B2 (fi)
WO1998013357A1 (fr) Derives de benzo[1,4]thiazine et medicaments les contenant
JPH01110679A (ja) １，５−ベンゾチアゼピン誘導体
FI93213B (fi) Menetelmä (+)-(2S,3S)-3-hydroksi-2-(4-metoksifenyyli)-2,3-dihydro-5H-1,5-bentsotiatsepiini-4-onin ja sen kloorattujen johdannaisten valmistamiseksi
JPS6261030B2 (fi)
JPS58159461A (ja) ジヒドロピリジン誘導体
JPS58216158A (ja) １，４−ジヒドロピリジン誘導体又はその塩類
BE819580A (fr) Nouvelles quinazolines et procede pour leur preparation
CS249525B2 (cs) Způsob výroby dihydropyridinů
HU191498B (en) Process for producing acridinone derivatives
BE896927A (fr) Derives d'isoquinoleine, leur procede de preparation et medicament les contenant